BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18296749)

  • 1. Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect.
    Olsson A; Lind L; Thornell LE; Holmberg M
    Hum Mol Genet; 2008 Jun; 17(11):1666-72. PubMed ID: 18296749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The defective splicing caused by the ISCU intron mutation in patients with myopathy with lactic acidosis is repressed by PTBP1 but can be derepressed by IGF2BP1.
    Nordin A; Larsson E; Holmberg M
    Hum Mutat; 2012 Mar; 33(3):467-70. PubMed ID: 22125086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical manifestation and a new ISCU mutation in iron-sulphur cluster deficiency myopathy.
    Kollberg G; Tulinius M; Melberg A; Darin N; Andersen O; Holmgren D; Oldfors A; Holme E
    Brain; 2009 Aug; 132(Pt 8):2170-9. PubMed ID: 19567699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligonucleotide therapeutics for iron-sulphur cluster deficiency myopathy.
    Kollberg G; Holme E
    Neuromuscul Disord; 2009 Dec; 19(12):833-6. PubMed ID: 19846308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The High Level of Aberrant Splicing of ISCU in Slow-Twitch Muscle May Involve the Splicing Factor SRSF3.
    Rawcliffe DF; Österman L; Lindsten H; Holmberg M
    PLoS One; 2016; 11(10):e0165453. PubMed ID: 27783661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific splicing of ISCU results in a skeletal muscle phenotype in myopathy with lactic acidosis, while complete loss of ISCU results in early embryonic death in mice.
    Nordin A; Larsson E; Thornell LE; Holmberg M
    Hum Genet; 2011 Apr; 129(4):371-8. PubMed ID: 21165651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTBP1 acts as a dominant repressor of the aberrant tissue-specific splicing of ISCU in hereditary myopathy with lactic acidosis.
    Rawcliffe DFR; Österman L; Nordin A; Holmberg M
    Mol Genet Genomic Med; 2018 Nov; 6(6):887-897. PubMed ID: 30209894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotide corrects splice abnormality in hereditary myopathy with lactic acidosis.
    Sanaker PS; Toompuu M; McClorey G; Bindoff LA
    Gene; 2012 Feb; 494(2):231-6. PubMed ID: 22155317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A homozygous splice mutation in the HSF4 gene is associated with an autosomal recessive congenital cataract.
    Smaoui N; Beltaief O; BenHamed S; M'Rad R; Maazoul F; Ouertani A; Chaabouni H; Hejtmancik JF
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2716-21. PubMed ID: 15277496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
    J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy.
    Sanaker PS; Toompuu M; Hogan VE; He L; Tzoulis C; Chrzanowska-Lightowlers ZM; Taylor RW; Bindoff LA
    Biochim Biophys Acta; 2010 Jun; 1802(6):539-44. PubMed ID: 20206689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.
    Thi Tran HT; Takeshima Y; Surono A; Yagi M; Wada H; Matsuo M
    Mol Genet Metab; 2005 Jul; 85(3):213-9. PubMed ID: 15979033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient restoration of succinate dehydrogenase activity after rhabdomyolysis in iron-sulphur cluster deficiency myopathy.
    Kollberg G; Melberg A; Holme E; Oldfors A
    Neuromuscul Disord; 2011 Feb; 21(2):115-20. PubMed ID: 21196119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
    Davis RL; Homer VM; George PM; Brennan SO
    Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants.
    Mukhopadhyay A; Nikopoulos K; Maugeri A; de Brouwer AP; van Nouhuys CE; Boon CJ; Perveen R; Zegers HA; Wittebol-Post D; van den Biesen PR; van der Velde-Visser SD; Brunner HG; Black GC; Hoyng CB; Cremers FP
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3565-72. PubMed ID: 16877430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of acceptor splice site of the SEDL gene in X-linked spondyloepiphyseal dysplasia tarda causes the activation of cryptic splice site.
    Ma HW; Jiang J; Lu JF; Guo R; Niu GH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):251-3. PubMed ID: 15952107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene.
    Hoshiya M; Christian BP; Cromie WJ; Kim H; Zhan Y; MacLaughlin DT; Donahoe PK
    Birth Defects Res A Clin Mol Teratol; 2003 Oct; 67(10):868-74. PubMed ID: 14745940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing pattern.
    Dall'Osso C; Guella I; Duga S; Locatelli N; Paraboschi EM; Spreafico M; Afrasiabi A; Pechlaner C; Peyvandi F; Tenchini ML; Asselta R
    Haematologica; 2008 Oct; 93(10):1505-13. PubMed ID: 18728029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines.
    Holmes-Hampton GP; Crooks DR; Haller RG; Guo S; Freier SM; Monia BP; Rouault TA
    Hum Mol Genet; 2016 Dec; 25(23):5178-5187. PubMed ID: 28007899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.